Skip to main content
Screener/Healthcare/Biotechnology

NBIX — Neurocrine Biosciences, Inc.

NASDAQ
$156.63-2.83 (-1.77%)
Large CapHealthcareFastest GrowingLow Beta
$122.14
$169.57
$155.30
$161.66
EPS (TTM)$4.66
P/E Ratio33.61
Dividend Yield—
Market Cap$16.40B
Volume550K
Prev Close$159.51
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$805.5M$153.7M$1.4897.8%19.1%
Q3 '25$794.9M$209.5M$2.0498.2%26.4%
Q2 '25$687.5M$107.5M$1.0698.4%15.6%
Q1 '25$572.6M$7.9M$0.0898.4%1.4%
Q4 '24$627.7M$103.1M$1.0098.5%16.4%
Q3 '24$622.1M$129.8M$1.2498.7%20.9%
Q2 '24$590.2M$65.0M$0.6398.4%11.0%
Q1 '24$515.3M$43.4M$0.4298.5%8.4%
Get Your Daily Market Recap